期刊
JOURNAL OF FUNGI
卷 7, 期 2, 页码 -出版社
MDPI
DOI: 10.3390/jof7020084
关键词
endogenous lichen fungus; Daldinia fissa; 5-hydroxy-2-methyl-chroman-4-one; selective monoamine oxidase B inhibitor; blood-brain barrier permeability; docking simulation
资金
- National Research Foundation of Korea (NRF) - Korea government [NRF-2019R1A2C1088967]
- Korea Institute of Toxicology, Republic of Korea [1711121217]
The study found that HMC is a substance with high selective inhibitory activity against MAO-B and can be considered as a candidate for the treatment of neurodegenerative diseases.
Inhibitory activities against monoamine oxidases (MAOs) and cholinesterases (ChEs) and antioxidant activity were evaluated for 195 extracts from Ukraine-derived endogenous lichen fungi (ELF). Among them, an ELF13 (identified as Daldinia fissa) extract showed the highest inhibitory activity against MAO-B, and 5-hydroxy-2-methyl-chroman-4-one (HMC) was isolated as a similar to 4-fold selective inhibitor of MAO-B (IC50 = 3.23 mu M) compared to MAO-A (IC50 = 13.97 mu M). HMC is a reversible competitive inhibitor with a K-i value of 0.896 mu M. No cytotoxicity was observed in normal and cancer cells at 50 mu M of HMC. HMC showed blood-brain barrier permeability and high gastrointestinal absorption in silico pharmacokinetics. The docking simulation results showed that the binding affinity of HMC for MAO-B (-7.3 kcal/mol) was higher than that of MAO-A (-6.1 kcal/mol) and that HMC formed a hydrogen bond interaction with Cys172 of MAO-B (distance: 3.656 angstrom), whereas no hydrogen bonding was predicted with MAO-A. These results suggest that HMC can be considered a candidate for the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据